Open original FDA record ↗Recall record
- FDA identifier
- Z-2256-2018
- Company in FDA record
- PENTAX of America Inc
- FDA classification date
- Jun 5, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The catheter alignment arrow printed onto the strain relief is not aligned with the detachment feature of the catheter connector, resulting in the potential for the catheter to be attached to the controller in the detach orientation. In this orientation, the catheter is not securely attached to the controller and may be partially (~1cm) ejected from controller.
Source facts
- Action
- On 3/30/2018, C2 Therapeutics issued URGENT FIELD CORRECTION notices to customers via certified mail, return receipt requested. Customers are advised to take the following Action: - Forward a copy of the notice and the enclosures to the department in which is referenced in the notice. - Inspect stock and quarantine products identified within the notice. - The end user of the affected products should complete and return the response form via email to RMA@c2therapeutics.com. The response form contains an RMA number to allow for the return of devices affected by this field action, and enclosed in the package is a Federal Express shipping label for the returned merchandise. Customers with questions can call 650-318-5899, Monday through Friday 8:30 AM - 5 PM, PST.
- Initiated
- 2018-03-30
- Root cause
- Vendor change control
- Terminated
- 2021-04-28
- Distribution
- Distribution US nationwide.
- Recall number
- Z-2256-2018
- Recall status
- Terminated
- CDRH record ID
- 164786
- FDA classified
- 2018-06-05
- Recall event number
- 80180